Vanda Pharmaceuticals | VNDA - EPS Earnings Per Share


Vanda Pharmaceuticals reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.46 0.4 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Ligand Pharmaceuticals USD 2.67 0.3 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD 0.38 2.35 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 3.55 1.46 Sep/2026
Takeda JPY 116.95 45.3 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Veracyte USD 0.51 0.03 Sep/2026